Clinical Trial Update: Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares modified-release hydrocortisone with conventional hydrocortisone to evaluate diurnal fatigue in secondary adrenal insuffici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)
• Hydrocortisone (modified-release formulation) (hydrocortisone)

Snippet

Sponsor: Ulla Feldt-Rasmussen | Conditions: Adrenal Insufficiency | Phase 4 | Status: UNKNOWN